Pyridazinedione-based heterobicyclic covalent linkers and methods and applications thereof
US-2024425465-A1 · Dec 26, 2024 · US
US9062004B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9062004-B2 |
| Application number | US-201113576872-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 7, 2011 |
| Priority date | Feb 8, 2010 |
| Publication date | Jun 23, 2015 |
| Grant date | Jun 23, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present specification discloses cannabinoid-2 agonists, compositions comprising such cannabinoid-2 agonists, and methods of treating an individual suffering from a disease by administering compositions comprising such cannabinoid-2 agonists. (Formula I and III)
Opening claim text (preview).
We claim: 1. A compound of formula I or a pharmaceutically acceptable salt thereof: wherein: R is selected from the group consisting of H and halogen; R 1 is H; R 2 is unsubstituted or substituted alkyl; R 3 is selected from the group consisting of H and unsubstituted or substituted alkyl; and Q is the ring-structure of formula II:…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.